Opiyatların (Morfin, Eroin, Kodein, Metadon vb.) Kullanım Bozukluğu ve Ebelik Yaklaşımı
References
Geraghty S, Doleman G, De Leo A. Midwives’ attitudes towards pregnant women using substances: Informing a care pathway. Women Birth. 2019;32(4): 477-482. doi:10.1016/j.wombi.2018.09.007
Forray A. Substance use during pregnancy. F1000Research. 2016; 5: F1000 Faculty Rev-887. doi: 10.12688/f1000research.7645.1
Krans EE, Patrick SW. Opioid use disorder in pregnancy: Health policy and practice in the midst of an epidemic. Obstet Gynecol. 2016;128(1): 4. doi: 10.1097/AOG.0000000000001446.
Loughran TA, Larroulet P, Thornberry TP. Definitional elasticity in the measurement of intergenerational continuity in substance use. Child Dev. 2018;89(5): 1625-1641. doi:10.1111/cdev.12849
Ebrahim SH, Gfroerer J. Pregnancy-related substance use in the United States during 1996–1998. Obstet Gynecol. 2003;101(2): 374-379. doi:10.1016/S0029-7844(02)02588-7
Forray A, Merry B, Lin H, Ruger JP, Yonkers KA. Perinatal substance use: A prospective evaluation of abstinence and relapse. Drug Alcohol Depend. 2015;150: 147-155. doi:10.1016/j.drugalcdep.
Bose J, Hedden SL, Lipari RN, Park-Lee E. Key Substance Use and Mental Health Indicators in the United States: Results from the 2017. National Survey on Drug Use and Health. Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2018. Erişim Linki: https://www.samhsa.gov/data/sites/default/files/cbhsq-reports/NSDUHFFR2017/NSDUHFFR2017.pdf Erişim Tarihi: 09.03.2024.
Kılıç FS. Opioidler, ağrı, opioidlerin suistimali ve yanlış kullanımı. Osmangazi Tıp Dergisi. 2017;39(3): 125-129. doi: 10.20515/otd. 333567
U.S. Department of Health & Human Services, Office of the Surgeon General. Facing Addiction in America: The Surgeon General’s Report on Alcohol, Drugs, and Health. Washington (DC): US Department of Health and Human Services; 2016. Erişim Linki: https://www.ncbi.nlm.nih.gov/books/NBK424857 Erişim Tarihi: 09.03.2024.
Committee on Obstetric Practice. Committee Opinion No. 711: Opioid Use and Opioid Use Disorder in Pregnancy. Obstet Gynecol. 2017;130(2): 488-489. doi: 10.1097/AOG.0000000000002229
Amerikan Psikiyatri Birliği. Madde ile İlişkili Bozukluklar ve Bağımlılık Bozuklukları. Köroğlu E. (Çeviri ed.) DSM-5 Tanı Ölçütleri Başvuru El Kitabı. 5. Baskı, Ankara: Hekimler Yayın Birliği Yayıncılık, 2013; 231-290.
Ailes EC, Dawson AL, Lind JN, Gilboa SM, Frey MT, Broussard CS, Honein MA. Opioid prescription claims among women of reproductive age United States, 2008-2012. MMWR Morb Mortal Wkly Rep. 2015;64(2): 37-41.
Ghelardini C, Di Cesare Mannelli L, Bianchi E. The pharmacological basis of opioids. Clin Cases Miner Bone Metab. 2015;12(3): 219-221. doi: 10.11138/ccmbm/2015.12.3.219
Pathan H, Williams J. Basic opioid pharmacology: An update. Br J Pain. 2012;6(1): 11-16. doi: 10.1177/2049463712438493
Blandthorn J, Leung L, Loke Y, Lloyd-Jones DM, Thurman R, Bowman E, Bonomo Y. Prescription opioid use in pregnancy. Aust N Z J Obstet Gynaecol. 2018;58: 494-498 doi: 10.1111/ajo.12823
Lossignol D. Morphine derivatives. Belgian J Medical Oncology. 2014;8(1): 9-13.
Akyüzlü DK. Buprenorfin farmakokinetiğinde ve farmakodinamiğinde rol oynayan gen polimorfizmleri: Genel bakış. Bağımlılık Dergisi. 2023;24(3): 391-401. doi: 10.51982/bagimli.1203151
Davis MP, Pasternak G, Behm B. Treating chronic pain: an overview of clinical studies centered on the buprenorphine option. Drugs. 2018;78(12): 1211-1228.
Han L, Yan W, Zheng Y, Khan MZ, Yuan K, Lu L. The rising crisis of illicit fentanyl use, overdose, and potential therapeutic strategies. Transl Psychiatry. 2019;9: 282. doi: 10.1038/s41398-019-0625-0.
Khaja M, Lominadze G, Millerman K. Cardiac arrest following drug abuse with intravenous Tapentadol: Case report and literature review. Am. J. Med. Case Rep. 2017;18: 817-821. Doi: 10.12659/AJCR.904695
Özdemir M, Aydın R. Ağrı kesici. Bölüm 4, İçinde: Ebeler İçin Farmakoloji. (Eds. M. Özdemir, S. Yazıcı, R. Aydın Doğan). Ankara Nobel Kitapevleri, 2021; ss. 103-104.
Sahafi A, Berry AJ, Sumnall H, Wood DM, Tracy DK. Synthetic opioids: a review and clinical update. Ther Adv Psychopharmacol. 2022;12: 20451253221139616. doi: 10.1177/20451253221139616
T.C. Sağlık Bakanlığı Sağlık Hizmetleri Genel Müdürlüğü. Madde bağımlılığı tanı ve tedavi kılavuzu el kitabı. 2012: ss. 63-104. ISBN: 978-975-590-431-3
Terplan M, Hand DJ, Hutchinson M, Salisbury Afs-har E, Heil SH, Contraceptive use and method choice among women with opioid and other substance use disorders: A systematic review. Prev Med. 2015;80: 23-31.
Klaman SL, Turner K, Lorvich J, Jones HE. Integrating reproductive and sexual health education and services ınto opioid use disorder treatment programs: A qualitative study. J Addict Med. 2020;14(5): 175-182. doi: 10.1097/ADM.0000000000000657.
Sharma AK, Aggarwal OP, Dubey KK. Sexual behavior of drug-users: Is it different? Prevent Med. 2002;34(5): 512-515.
Wilson N, Kariisa M, Seth P, Smith H IV, Davis NL. Drug and opioid involved overdose deaths-United States, 2017-2018. MMWR Morb Mortal Wkly Rep. 2020;69(11): 290-297. doi:10.15585/mmwr.mm6911a4
Ko JY, D’Angelo DV, Haight SC, Morrow B, Cox S, von Essen BS, et al. Vital signs: Prescription opioid pain reliever use during pregnancy- 34 U.S. Jurisdictions, 2019. MMWR Morb Mortal Wkly Rep. 2020;69(28): 897-903. doi: 10.15585/mmwr.mm6928a1
Ryan KS, Prewitt KC, Hayer S, Hedges MA, Benson AE, Lo JO. Opioid use in pregnancy: A Review. Obstet. Gynecol. Surv. 2023;78(1): 35-49. doi: 10.1097/OGX.0000000000001094.
Flannagan KS, Mumford SL, Sjaarda LA, Radoc JG. Perkins NJ, Andriessen VC, Zolton JR, Silver RM, Schisterman E. Is opioid use safe in women trying to conceive? Epidemiology. 2020;31(6): 844-851. doi:10.1097/EDE.0000000000001247
Flannagan KS, Sjaarda LA, Mumford SL, Schisterman EF. Prescription opioid use among populations of reproductive age: Effects on fertility, pregnancy loss, and pregnancy complications. Epidemiol Rev. 2020;42(1): 117-133. doi: 10.1093/epirev/mxaa007.
Yalnız Dilcen H, Türkmen H. Madde kullanımı olan ebelerde ebelik yaklaşımı. İçinde: Sağlık Bilimlerinde Multidisipliner Araştırmalar (Ed. A. Dinç). Efe Akademi, 2020; ss. 217-233. ISBN: 978-625-7729-16-1
Griffiths SK, Campbell JP. Placental structure, function and drug transfer. Contin Educ Anaesth Crit Care Pain. 2014;15(2): 84-89. doi: 10.1093/bjaceaccp/mku013
Van Hoogdalem MW, Wexelblatt SL, Akinbi HT, Winks AA, Mizuno T. A review of pregnancy-induced changes in opioid pharmacokinetics, placental transfer, and fetal exposure: Towards fetomaternal physiologically-based pharmacokinetic modeling to improve the treatment of neonatal opioid withdrawal syndrome. Pharmacol Ther. 2022;234: 108045. doi:10.1016/j.pharmthera.2021.108045
Cohen A, Osorio R, Page LM. Substance misuse in pregnancy. Obstet Gynaecol Reprod Med. 2017;27(10): 316-321. doi:10.1016/j.ogrm.2017.07.003
Ludlow JP, Evans SF, Hulse G. Obstetric and perinatal outcomes in pregnancies associated with illicit substance abuse. Aust N Z J Obstet Gynaecol. 2004;44(4): 302-306. doi: 10.1111/j.1479-828X.2004.00221.x.
Lind JN, Interrante JD, Ailes EC, Gilboa SM, Khan S, T. Frey MT. et al. Maternal use of opioids during pregnancy and congenital malformations: A systematic review. Pediatrics. 2017;139(6): e20164131. doi:10.1542/peds.2016-4131.
Broussard CS, Rasmussen SA, Reefhuis J, Friedman JM, Jann MW, Riehle-Colarusso T, Honein MA, National Birth Defects Prevention Study. Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol. 2011;204(4): 314.e1-314.e11. doi:10.1016/j.ajog.2010.12.039
ACOG - The American College of Obstetricians and Gynecologists. Opioid use and opioid use disorders in pregnancy, Number 711, 2017. Erişim Linki: https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2017/08/opioid-use-and-opioid-use-disorder-in-pregnancy Erişim Tarihi: 17.03.2024
Baldacchino A, Arbuckle K, Petrie DJ, McCowan C. Erratum: Neurobehavioral consequences of chronic intrauterine opioid exposure in infants and preschool children: A systematic review and meta-analysis. BMC Psychiatry. 2015;15: 134. doi: 10.1186/s12888-015-0438-5
Lee SJ, Bora S, Austin NC, Westerman A, Henderson JMT. Neurodevelopmental outcomes of children born to opioid-dependent mothers: A systematic review and meta-analysis. Acad Pediatr. 2020;20(3): 308-318. doi: 10.1016/j.acap.2019.11.005.
Aslan R, Aktaş A, Akgür SA. Çocuk ve ergenlerde madde kullanımı ve adli toksikolojik analizler. Bağımlılık Dergisi. 2023;24(1): 93-103. doi: 10.51982/bagimli.1071269
Marin SJ, Doyle K, Chang A, Concheiro-Guisan M, Huestis MA, Johnson-Davis KL. One hundred false-positive amphetamine specimens characterized by liquid chromatography time-of-flight mass spectrometry. J Anal Toxicol. 2016;40(1): 37-42. doi: 10.1093/jat/bkv101.
Colby JM. Comparison of umbilical cord tissue and meconium for the confirmation of in utero drug exposure. Clin Biochem. 2017;50(13-14): 784-790. doi: 10.1016/j.clinbiochem.2017.03.006.
Wong S, Ordean A, Kahan M., Maternal Fetal Medicine Committee. Family Physicians Advisory Committee. Medico-Legal Committee. AD Hoc Reviewers. Special Contributors. Substance use in pregnancy. J Obstet Gynaecol Can. 2011;33(4): 367-384. doi: 10.1016/S1701-2163(16)34855-1.
Carley JA, Oesterle T. Therapeutic approaches to opioid use disorder: What is the current standard of care? Int J Gen Med. 2021;14: 2305-2311. doi: 10.2147/IJGM.S295461
Kırlı U, Nart Ö. Opioid kullanım bozukluğu sürdürüm tedavisinde naltrekson implant ile oral buprenorfin-nalokson kullanan hastaların tedaviyi yarıda bırakma risklerinin karşılaştırılması. Klinik Psikiyatri Dergisi. 2021;24: 342-349 doi: 10.5505/kpd.2021.3708
WHO Group Consultation on Health Telematics. A Health Telematics Policy in Support of WHO’s Health-for-all Strategy for Global Health Development: Report of the WHO Group Consultation on Health Telematics, December 11-16, 1997, Geneva, Switzerland. Geneva, Switzerland: World Health Organization; 1998. Erişim Linki: https://iris.who.int/bitstream/handle/10665/63857/WHO_;jsessionid=011417C19EA6092159793FE1D7A09E6A?sequence=1 Erişim Tarihi: 16.03.2024
Guille C, Simpson AN, Douglas E, Boyars L, Cristaldi K, McElligott J, Johnson D, Brady K. Treatment of opioid use disorder in pregnant women via telemedicine: A nonrandomized controlled trial. JAMA Netw Open. 2020;3(1): e1920177. doi: 10.1001/jamanetworkopen.2019.20177
Dugosh K, Abraham A, Seymour B, McLoyd K, Chalk M, Festinger D. Review on the use of psychosocial interventions in conjunction with medications for the treatment of opioid addiction. J Addict Med. 2016;10(2): 91-101. doi: 10.1097/ADM.0000000000000193
Carroll KM, Onken LS. Behavioral therapies for drug abuse. Am J Psychiatry. 2005;162(8): 1452-1460. doi: 10.1176/appi.ajp.162.8.1452
Dutra L, Stathopoulou G, Basden SL, Leyro TM, Powers MB, Otto MW. A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry. 2008;165(2): 179-187. doi: 10.1176/appi.ajp.2007.06111851
Shah S, Banh ET, Koury K, Bhatia G, Nandi R, Gulur P. Pain management in pregnancy: Multimodal approaches. Pain Res Treat. 2015;2015: 987483. doi: 10.1155/2015/987483.
Soens MA, He J, Bateman BT. Anesthesia considerations and post-operative pain management in pregnant women with chronic opioid use. Semin Perinatol. 2019;43(3): 149-161. doi: 10.1053/j.semperi.2019.01.004.
Holbrook A, Kaltenbach K. Co-occurring psychiatric symptoms in opioid-dependent women: The prevalence of antenatal and postnatal depression. Am J Drug Alcohol Abuse. 2012;38(6): 575-579. doi: 10.3109/00952990.2012.696168.
Hale TW, Krutsch K. Opioid use in breastfeeding mothers and neonatal risks. Clin Pharmacol Ther. 2021;109(3): 573-575. doi:10.1002/cpt.211
Anderson PO. Opioid use in breastfeeding. Breastfeed Med. 2021;16(5): 366-369. doi:10.1089/bfm.2021.0039
Fischbein RL, Lanese BG, Falletta L, Hamilton K, King JA, Kenne DR. Pregnant or recently pregnant opioid users:Contraception decisions, perceptions and preferences. Contracept Reprod Med. 2018;3(1): 4. doi: 10.1186/s40834-018-0056-y
Mundt-Leach R. Contraception needs of women attending drug and alcohol treatment centres. Mental Health Practice. 2014;17(6): 29-34. doi: 10.7748/mhp2014.03.17.6.29.e842
Jessup MA, Brindis CD. Issues in reproductive health and empowerment in perinatal women with substance use disorders. J Addict Nurs. 2005;16(3): 97-105. doi: 10.1080/10884500500196693
Black KI, Day CA. Improving access to long-acting contraceptive methods and reducing unplanned pregnancy among women with substance use disorders. J Subst Abuse Treat. 2016;10(Suppl 1): 27-33. doi: 10.4137/SART.S34555
Edelman NL, Patel H, Glasper A, Bogen‐Johnston L. Sexual health risks and health-seeking behaviours among substance-misusing women. J Adv Nurs. 2014;70(12): 2861-2870. doi:10.1111/jan.12442
Neale J, Werthern H, Alhusein N, Chater A, Scott J, Family H. Contraceptive choice and power amongst women receiving opioid replacement therapy: Qualitative study. Drugs: Educ Prev Policy. 2022;29(6): 655-666. doi: 10.1080/09687637.2021.1954599
Gee RE, Mitra N, Wan F, Chavkin DE, Long JA. Power over parity: Intimate partner violence and issues of fertility control. Am J Obstet Gynecol. 2009;201(2): 148.e1-e1. doi: 10.1016/j.ajog.2009.04.048
Cleveland LM. Breastfeeding recommendations for women who receive medicationassisted treatment for opioid use disorders: AWHONN Practice Brief Number 4. J Obstet Gynecol Neonatal Nurs. 2016;45(4): 574-576.
CDC-Centers for Disease Control and Prevention. When should a mother avoid breastfeeding (contraindications)? 2022. Erişim Linki: https://www.cdc.gov/breastfeeding/faq/index.htm Erişim Tarihi: 18.03.2024
CDC-Centers for Disease Control and Prevention. Mothers with Hepatitis B or C infections can breastfeed their infants. 2023 Erişim Linki: https://www.cdc.gov/breastfeeding/breastfeeding-special-circumstances/maternal-or-infant-illnesses/hepatitis.html#:~:text=Is%20it%20safe%20for%20a,within%2012%20hours%20of%20birth. Erişim Tarihi: 18.03.2024
67Artigas V. Management of neonatal abstinence syndrome in the newborn nursery. Nurs Womens Health. 2014;18(6): 509-514. doi: 10.1111/1751-486X.12163.
Rizk AH, Simonsen SE, Roberts L, Taylor-Swanson L, Lemoine JB, Smid M. Maternity care for pregnant women with opioid use disorder: A review. J Midwifery Womens Health. 2019;64(5): 532-544. doi:10.1111/jmwh.13019.
Hudak ML, Tan RC. Committee on Drugs; Committee on Fetus and Newborn; American Academy of Pediatrics. Neonatal drug withdrawal. Pediatrics. 2012;129(2): 540-560. doi: 10.1542/peds.2011-3212.
Mangat AK, Schmölzer GM, Kraft WK. Pharmacological and non-pharmacological treatments for the Neonatal Abstinence Syndrome (NAS). Semin Fetal Neonat Med. 2019;24(2): 133-141. doi: 10.1016/j.siny.2019.01.009
Bozkaya D, Öktem A, Yurdakök M. Eroin kullanan anne ve neonatal yoksunluk sendromu. Çocuk Sağlığı ve Hastalıkları Dergisi. 2016;59: 72-75.
Elbayiyev S, Çakır U. Madde bağımlısı anne bebeklerinin klinik ve laboratuvar özellikleri: tek merkez deneyimi. Bağımlılık Dergisi. 2023;24(1): 35-42. doi: 10.51982/bagimli.1141958
Forray A. Substance use during pregnancy. F1000Research. 2016; 5: F1000 Faculty Rev-887. doi: 10.12688/f1000research.7645.1
Krans EE, Patrick SW. Opioid use disorder in pregnancy: Health policy and practice in the midst of an epidemic. Obstet Gynecol. 2016;128(1): 4. doi: 10.1097/AOG.0000000000001446.
Loughran TA, Larroulet P, Thornberry TP. Definitional elasticity in the measurement of intergenerational continuity in substance use. Child Dev. 2018;89(5): 1625-1641. doi:10.1111/cdev.12849
Ebrahim SH, Gfroerer J. Pregnancy-related substance use in the United States during 1996–1998. Obstet Gynecol. 2003;101(2): 374-379. doi:10.1016/S0029-7844(02)02588-7
Forray A, Merry B, Lin H, Ruger JP, Yonkers KA. Perinatal substance use: A prospective evaluation of abstinence and relapse. Drug Alcohol Depend. 2015;150: 147-155. doi:10.1016/j.drugalcdep.
Bose J, Hedden SL, Lipari RN, Park-Lee E. Key Substance Use and Mental Health Indicators in the United States: Results from the 2017. National Survey on Drug Use and Health. Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2018. Erişim Linki: https://www.samhsa.gov/data/sites/default/files/cbhsq-reports/NSDUHFFR2017/NSDUHFFR2017.pdf Erişim Tarihi: 09.03.2024.
Kılıç FS. Opioidler, ağrı, opioidlerin suistimali ve yanlış kullanımı. Osmangazi Tıp Dergisi. 2017;39(3): 125-129. doi: 10.20515/otd. 333567
U.S. Department of Health & Human Services, Office of the Surgeon General. Facing Addiction in America: The Surgeon General’s Report on Alcohol, Drugs, and Health. Washington (DC): US Department of Health and Human Services; 2016. Erişim Linki: https://www.ncbi.nlm.nih.gov/books/NBK424857 Erişim Tarihi: 09.03.2024.
Committee on Obstetric Practice. Committee Opinion No. 711: Opioid Use and Opioid Use Disorder in Pregnancy. Obstet Gynecol. 2017;130(2): 488-489. doi: 10.1097/AOG.0000000000002229
Amerikan Psikiyatri Birliği. Madde ile İlişkili Bozukluklar ve Bağımlılık Bozuklukları. Köroğlu E. (Çeviri ed.) DSM-5 Tanı Ölçütleri Başvuru El Kitabı. 5. Baskı, Ankara: Hekimler Yayın Birliği Yayıncılık, 2013; 231-290.
Ailes EC, Dawson AL, Lind JN, Gilboa SM, Frey MT, Broussard CS, Honein MA. Opioid prescription claims among women of reproductive age United States, 2008-2012. MMWR Morb Mortal Wkly Rep. 2015;64(2): 37-41.
Ghelardini C, Di Cesare Mannelli L, Bianchi E. The pharmacological basis of opioids. Clin Cases Miner Bone Metab. 2015;12(3): 219-221. doi: 10.11138/ccmbm/2015.12.3.219
Pathan H, Williams J. Basic opioid pharmacology: An update. Br J Pain. 2012;6(1): 11-16. doi: 10.1177/2049463712438493
Blandthorn J, Leung L, Loke Y, Lloyd-Jones DM, Thurman R, Bowman E, Bonomo Y. Prescription opioid use in pregnancy. Aust N Z J Obstet Gynaecol. 2018;58: 494-498 doi: 10.1111/ajo.12823
Lossignol D. Morphine derivatives. Belgian J Medical Oncology. 2014;8(1): 9-13.
Akyüzlü DK. Buprenorfin farmakokinetiğinde ve farmakodinamiğinde rol oynayan gen polimorfizmleri: Genel bakış. Bağımlılık Dergisi. 2023;24(3): 391-401. doi: 10.51982/bagimli.1203151
Davis MP, Pasternak G, Behm B. Treating chronic pain: an overview of clinical studies centered on the buprenorphine option. Drugs. 2018;78(12): 1211-1228.
Han L, Yan W, Zheng Y, Khan MZ, Yuan K, Lu L. The rising crisis of illicit fentanyl use, overdose, and potential therapeutic strategies. Transl Psychiatry. 2019;9: 282. doi: 10.1038/s41398-019-0625-0.
Khaja M, Lominadze G, Millerman K. Cardiac arrest following drug abuse with intravenous Tapentadol: Case report and literature review. Am. J. Med. Case Rep. 2017;18: 817-821. Doi: 10.12659/AJCR.904695
Özdemir M, Aydın R. Ağrı kesici. Bölüm 4, İçinde: Ebeler İçin Farmakoloji. (Eds. M. Özdemir, S. Yazıcı, R. Aydın Doğan). Ankara Nobel Kitapevleri, 2021; ss. 103-104.
Sahafi A, Berry AJ, Sumnall H, Wood DM, Tracy DK. Synthetic opioids: a review and clinical update. Ther Adv Psychopharmacol. 2022;12: 20451253221139616. doi: 10.1177/20451253221139616
T.C. Sağlık Bakanlığı Sağlık Hizmetleri Genel Müdürlüğü. Madde bağımlılığı tanı ve tedavi kılavuzu el kitabı. 2012: ss. 63-104. ISBN: 978-975-590-431-3
Terplan M, Hand DJ, Hutchinson M, Salisbury Afs-har E, Heil SH, Contraceptive use and method choice among women with opioid and other substance use disorders: A systematic review. Prev Med. 2015;80: 23-31.
Klaman SL, Turner K, Lorvich J, Jones HE. Integrating reproductive and sexual health education and services ınto opioid use disorder treatment programs: A qualitative study. J Addict Med. 2020;14(5): 175-182. doi: 10.1097/ADM.0000000000000657.
Sharma AK, Aggarwal OP, Dubey KK. Sexual behavior of drug-users: Is it different? Prevent Med. 2002;34(5): 512-515.
Wilson N, Kariisa M, Seth P, Smith H IV, Davis NL. Drug and opioid involved overdose deaths-United States, 2017-2018. MMWR Morb Mortal Wkly Rep. 2020;69(11): 290-297. doi:10.15585/mmwr.mm6911a4
Ko JY, D’Angelo DV, Haight SC, Morrow B, Cox S, von Essen BS, et al. Vital signs: Prescription opioid pain reliever use during pregnancy- 34 U.S. Jurisdictions, 2019. MMWR Morb Mortal Wkly Rep. 2020;69(28): 897-903. doi: 10.15585/mmwr.mm6928a1
Ryan KS, Prewitt KC, Hayer S, Hedges MA, Benson AE, Lo JO. Opioid use in pregnancy: A Review. Obstet. Gynecol. Surv. 2023;78(1): 35-49. doi: 10.1097/OGX.0000000000001094.
Flannagan KS, Mumford SL, Sjaarda LA, Radoc JG. Perkins NJ, Andriessen VC, Zolton JR, Silver RM, Schisterman E. Is opioid use safe in women trying to conceive? Epidemiology. 2020;31(6): 844-851. doi:10.1097/EDE.0000000000001247
Flannagan KS, Sjaarda LA, Mumford SL, Schisterman EF. Prescription opioid use among populations of reproductive age: Effects on fertility, pregnancy loss, and pregnancy complications. Epidemiol Rev. 2020;42(1): 117-133. doi: 10.1093/epirev/mxaa007.
Yalnız Dilcen H, Türkmen H. Madde kullanımı olan ebelerde ebelik yaklaşımı. İçinde: Sağlık Bilimlerinde Multidisipliner Araştırmalar (Ed. A. Dinç). Efe Akademi, 2020; ss. 217-233. ISBN: 978-625-7729-16-1
Griffiths SK, Campbell JP. Placental structure, function and drug transfer. Contin Educ Anaesth Crit Care Pain. 2014;15(2): 84-89. doi: 10.1093/bjaceaccp/mku013
Van Hoogdalem MW, Wexelblatt SL, Akinbi HT, Winks AA, Mizuno T. A review of pregnancy-induced changes in opioid pharmacokinetics, placental transfer, and fetal exposure: Towards fetomaternal physiologically-based pharmacokinetic modeling to improve the treatment of neonatal opioid withdrawal syndrome. Pharmacol Ther. 2022;234: 108045. doi:10.1016/j.pharmthera.2021.108045
Cohen A, Osorio R, Page LM. Substance misuse in pregnancy. Obstet Gynaecol Reprod Med. 2017;27(10): 316-321. doi:10.1016/j.ogrm.2017.07.003
Ludlow JP, Evans SF, Hulse G. Obstetric and perinatal outcomes in pregnancies associated with illicit substance abuse. Aust N Z J Obstet Gynaecol. 2004;44(4): 302-306. doi: 10.1111/j.1479-828X.2004.00221.x.
Lind JN, Interrante JD, Ailes EC, Gilboa SM, Khan S, T. Frey MT. et al. Maternal use of opioids during pregnancy and congenital malformations: A systematic review. Pediatrics. 2017;139(6): e20164131. doi:10.1542/peds.2016-4131.
Broussard CS, Rasmussen SA, Reefhuis J, Friedman JM, Jann MW, Riehle-Colarusso T, Honein MA, National Birth Defects Prevention Study. Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol. 2011;204(4): 314.e1-314.e11. doi:10.1016/j.ajog.2010.12.039
ACOG - The American College of Obstetricians and Gynecologists. Opioid use and opioid use disorders in pregnancy, Number 711, 2017. Erişim Linki: https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2017/08/opioid-use-and-opioid-use-disorder-in-pregnancy Erişim Tarihi: 17.03.2024
Baldacchino A, Arbuckle K, Petrie DJ, McCowan C. Erratum: Neurobehavioral consequences of chronic intrauterine opioid exposure in infants and preschool children: A systematic review and meta-analysis. BMC Psychiatry. 2015;15: 134. doi: 10.1186/s12888-015-0438-5
Lee SJ, Bora S, Austin NC, Westerman A, Henderson JMT. Neurodevelopmental outcomes of children born to opioid-dependent mothers: A systematic review and meta-analysis. Acad Pediatr. 2020;20(3): 308-318. doi: 10.1016/j.acap.2019.11.005.
Aslan R, Aktaş A, Akgür SA. Çocuk ve ergenlerde madde kullanımı ve adli toksikolojik analizler. Bağımlılık Dergisi. 2023;24(1): 93-103. doi: 10.51982/bagimli.1071269
Marin SJ, Doyle K, Chang A, Concheiro-Guisan M, Huestis MA, Johnson-Davis KL. One hundred false-positive amphetamine specimens characterized by liquid chromatography time-of-flight mass spectrometry. J Anal Toxicol. 2016;40(1): 37-42. doi: 10.1093/jat/bkv101.
Colby JM. Comparison of umbilical cord tissue and meconium for the confirmation of in utero drug exposure. Clin Biochem. 2017;50(13-14): 784-790. doi: 10.1016/j.clinbiochem.2017.03.006.
Wong S, Ordean A, Kahan M., Maternal Fetal Medicine Committee. Family Physicians Advisory Committee. Medico-Legal Committee. AD Hoc Reviewers. Special Contributors. Substance use in pregnancy. J Obstet Gynaecol Can. 2011;33(4): 367-384. doi: 10.1016/S1701-2163(16)34855-1.
Carley JA, Oesterle T. Therapeutic approaches to opioid use disorder: What is the current standard of care? Int J Gen Med. 2021;14: 2305-2311. doi: 10.2147/IJGM.S295461
Kırlı U, Nart Ö. Opioid kullanım bozukluğu sürdürüm tedavisinde naltrekson implant ile oral buprenorfin-nalokson kullanan hastaların tedaviyi yarıda bırakma risklerinin karşılaştırılması. Klinik Psikiyatri Dergisi. 2021;24: 342-349 doi: 10.5505/kpd.2021.3708
WHO Group Consultation on Health Telematics. A Health Telematics Policy in Support of WHO’s Health-for-all Strategy for Global Health Development: Report of the WHO Group Consultation on Health Telematics, December 11-16, 1997, Geneva, Switzerland. Geneva, Switzerland: World Health Organization; 1998. Erişim Linki: https://iris.who.int/bitstream/handle/10665/63857/WHO_;jsessionid=011417C19EA6092159793FE1D7A09E6A?sequence=1 Erişim Tarihi: 16.03.2024
Guille C, Simpson AN, Douglas E, Boyars L, Cristaldi K, McElligott J, Johnson D, Brady K. Treatment of opioid use disorder in pregnant women via telemedicine: A nonrandomized controlled trial. JAMA Netw Open. 2020;3(1): e1920177. doi: 10.1001/jamanetworkopen.2019.20177
Dugosh K, Abraham A, Seymour B, McLoyd K, Chalk M, Festinger D. Review on the use of psychosocial interventions in conjunction with medications for the treatment of opioid addiction. J Addict Med. 2016;10(2): 91-101. doi: 10.1097/ADM.0000000000000193
Carroll KM, Onken LS. Behavioral therapies for drug abuse. Am J Psychiatry. 2005;162(8): 1452-1460. doi: 10.1176/appi.ajp.162.8.1452
Dutra L, Stathopoulou G, Basden SL, Leyro TM, Powers MB, Otto MW. A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry. 2008;165(2): 179-187. doi: 10.1176/appi.ajp.2007.06111851
Shah S, Banh ET, Koury K, Bhatia G, Nandi R, Gulur P. Pain management in pregnancy: Multimodal approaches. Pain Res Treat. 2015;2015: 987483. doi: 10.1155/2015/987483.
Soens MA, He J, Bateman BT. Anesthesia considerations and post-operative pain management in pregnant women with chronic opioid use. Semin Perinatol. 2019;43(3): 149-161. doi: 10.1053/j.semperi.2019.01.004.
Holbrook A, Kaltenbach K. Co-occurring psychiatric symptoms in opioid-dependent women: The prevalence of antenatal and postnatal depression. Am J Drug Alcohol Abuse. 2012;38(6): 575-579. doi: 10.3109/00952990.2012.696168.
Hale TW, Krutsch K. Opioid use in breastfeeding mothers and neonatal risks. Clin Pharmacol Ther. 2021;109(3): 573-575. doi:10.1002/cpt.211
Anderson PO. Opioid use in breastfeeding. Breastfeed Med. 2021;16(5): 366-369. doi:10.1089/bfm.2021.0039
Fischbein RL, Lanese BG, Falletta L, Hamilton K, King JA, Kenne DR. Pregnant or recently pregnant opioid users:Contraception decisions, perceptions and preferences. Contracept Reprod Med. 2018;3(1): 4. doi: 10.1186/s40834-018-0056-y
Mundt-Leach R. Contraception needs of women attending drug and alcohol treatment centres. Mental Health Practice. 2014;17(6): 29-34. doi: 10.7748/mhp2014.03.17.6.29.e842
Jessup MA, Brindis CD. Issues in reproductive health and empowerment in perinatal women with substance use disorders. J Addict Nurs. 2005;16(3): 97-105. doi: 10.1080/10884500500196693
Black KI, Day CA. Improving access to long-acting contraceptive methods and reducing unplanned pregnancy among women with substance use disorders. J Subst Abuse Treat. 2016;10(Suppl 1): 27-33. doi: 10.4137/SART.S34555
Edelman NL, Patel H, Glasper A, Bogen‐Johnston L. Sexual health risks and health-seeking behaviours among substance-misusing women. J Adv Nurs. 2014;70(12): 2861-2870. doi:10.1111/jan.12442
Neale J, Werthern H, Alhusein N, Chater A, Scott J, Family H. Contraceptive choice and power amongst women receiving opioid replacement therapy: Qualitative study. Drugs: Educ Prev Policy. 2022;29(6): 655-666. doi: 10.1080/09687637.2021.1954599
Gee RE, Mitra N, Wan F, Chavkin DE, Long JA. Power over parity: Intimate partner violence and issues of fertility control. Am J Obstet Gynecol. 2009;201(2): 148.e1-e1. doi: 10.1016/j.ajog.2009.04.048
Cleveland LM. Breastfeeding recommendations for women who receive medicationassisted treatment for opioid use disorders: AWHONN Practice Brief Number 4. J Obstet Gynecol Neonatal Nurs. 2016;45(4): 574-576.
CDC-Centers for Disease Control and Prevention. When should a mother avoid breastfeeding (contraindications)? 2022. Erişim Linki: https://www.cdc.gov/breastfeeding/faq/index.htm Erişim Tarihi: 18.03.2024
CDC-Centers for Disease Control and Prevention. Mothers with Hepatitis B or C infections can breastfeed their infants. 2023 Erişim Linki: https://www.cdc.gov/breastfeeding/breastfeeding-special-circumstances/maternal-or-infant-illnesses/hepatitis.html#:~:text=Is%20it%20safe%20for%20a,within%2012%20hours%20of%20birth. Erişim Tarihi: 18.03.2024
67Artigas V. Management of neonatal abstinence syndrome in the newborn nursery. Nurs Womens Health. 2014;18(6): 509-514. doi: 10.1111/1751-486X.12163.
Rizk AH, Simonsen SE, Roberts L, Taylor-Swanson L, Lemoine JB, Smid M. Maternity care for pregnant women with opioid use disorder: A review. J Midwifery Womens Health. 2019;64(5): 532-544. doi:10.1111/jmwh.13019.
Hudak ML, Tan RC. Committee on Drugs; Committee on Fetus and Newborn; American Academy of Pediatrics. Neonatal drug withdrawal. Pediatrics. 2012;129(2): 540-560. doi: 10.1542/peds.2011-3212.
Mangat AK, Schmölzer GM, Kraft WK. Pharmacological and non-pharmacological treatments for the Neonatal Abstinence Syndrome (NAS). Semin Fetal Neonat Med. 2019;24(2): 133-141. doi: 10.1016/j.siny.2019.01.009
Bozkaya D, Öktem A, Yurdakök M. Eroin kullanan anne ve neonatal yoksunluk sendromu. Çocuk Sağlığı ve Hastalıkları Dergisi. 2016;59: 72-75.
Elbayiyev S, Çakır U. Madde bağımlısı anne bebeklerinin klinik ve laboratuvar özellikleri: tek merkez deneyimi. Bağımlılık Dergisi. 2023;24(1): 35-42. doi: 10.51982/bagimli.1141958
Pages
125-148
Published
January 22, 2025
Copyright (c) 2025 Academician Publishing Book Portal
